MRNA
0/8LiveModerna, Inc.
NasdaqGS · Healthcare · Biotechnology
$158.83
Blended fair value
$0.4678
Well above fair value
Margin of safety
-33851.02%
against blended fair value
Expected return
-39.91%
per year, mid case
52-week range
Valuation verdict
Based on your current assumptions
Well above fair value
Fair value $0.4678 against a market price of $158.83.
- Margin of safety
- -33851.02%
- Expected return
- -39.91%/ yr
Company facts
- Market cap
- $60.36B
- P/E (5yr avg)
- n/a
- Day range
- $141.21 – $161.37
- 52-week range
- $22.28 – $176.66
- Volume
- 49.0M
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 5,600
mRNA therapeutics platform funding an oncology and vaccine pipeline from a declining respiratory-vaccine revenue base.
Falls short on 8 pillars: p/e ratio, price to free cash flow, return on invested capital, revenue growth, net income growth, free cash flow growth, shares outstanding, long-term debt to fcf.
P/E ratio
Fail5yr average P/E below 22.5
Price to free cash flow
Fail5yr average P/FCF below 22.5
Return on invested capital
Fail5yr average ROIC above 9%
Revenue growth
Fail10yr CAGR above 0%
Net income growth
Fail10yr CAGR above 0%
Free cash flow growth
Fail10yr CAGR above 0%
Shares outstanding
FailShare count flat or shrinking over 5 years
Long-term debt to FCF
FailDebt payable from under 5 years of free cash flow
Everything Money is not an investment adviser. The fair-value range on this page is the arithmetic output of assumptions you control, not a forecast or a recommendation. Verify figures against the company's filings before acting. How the method works